Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
ANAB
#1840
AnaptysBio, Inc. Common Stock
55.050
0
+1.79%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+1.79%
Aylık değişim
+11.53%
6 aylık değişim
+56.39%
Yıllık değişim
+56.39%
Önceki kapanış
54.080
0
Open
55.050
0
Bid
Ask
Low
55.050
0
High
55.146
0
Hacim
74
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
ANAB
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
30.43 M
30.67 M
29.38 M
28 M
27.69 M
—
Valuation ratios
Enterprise value
827.78 M
282.95 M
447.55 M
577.23 M
737.99 M
2.05 B
Price to earnings ratio
-5.51
-2.59
-3.91
-5.06
-11.22
-22.76
Price to sales ratio
16.02
4.12
4.75
5.21
5.28
19.36
Price to cash flow ratio
-8.78
-2.78
-4.83
-5.03
-6.13
-18.76
Price to book ratio
3.96
5.3
2.65
4.31
28.07
40.34
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.07
0.05
0.09
0.12
0.04
0.3
Return on equity %
0.39
0.31
1.16
0.86
0.51
2.84
Return on invested capital %
167.79
76.13
190.36
197.25
244.78
708.52
Gross margin %
100
100
100
100
100
400
Operating margin %
75.81
22.43
99.16
117.55
45.47
284.62
EBITDA margin %
—
—
—
—
—
—
Net margin %
109.44
50.53
141.62
173.52
19.8
385.47
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.23
9.51
8.25
8.22
8.68
34.65
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.07
0.09
0.06
0.06
0.22
0.43
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.35
2.35
0.35
1.4
0.94
5.04
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
14.89
13.58
11.09
9.22
8.58
42.47
Net current asset value per share
15.53
15.22
11.85
10.13
11.39
48.59
Tangible book value per share
2.92
2.5
1.11
1.55
1.01
6.17
Working capital per share
14.01
13.62
10.41
8.9
10.08
43.01
Book value per share
2.92
2.5
1.11
1.55
1.01
6.17
Haberler
FDA akzeptiert Zulassungsantrag von Vanda für Medikament gegen seltene Hautkrankheit
FDA accepts Vanda’s imsidolimab application for rare skin disorder
AnaptysBio-Aktie erreicht 52-Wochen-Hoch bei 57,73 $
AnaptysBio stock hits 52-week high at $57.73
These IBD 50 Stocks Form Secondary Buy Areas, But Watch These Risks
AnaptysBio-Aktie erreicht 52-Wochen-Hoch von 52,56 $
AnaptysBio stock hits 52-week high at $52.56
Biotech Leader Eyes Spinoff Amid Massive Sales Surge
AnaptysBio: Direktorin verkauft Aktien im Wert von über 530.000 US-Dollar
AnaptysBio, Inc. (ANAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
AnaptysBio-Aktie: UBS bestätigt Kaufempfehlung trotz Rechtsstreit mit GSK/n
AnaptysBio stock: UBS reiterates Buy rating amid ongoing GSK litigation